HippoFi (formerly ORHub, Inc.) is a healthcare innovator and biotechnology powerhouse leading with the Authority in Regenerative Biologics, PUR Biologics
PUR Biologics Product Shipments Reach New Heights Amid Unprecedented Demand in August
We are thrilled to announce that August has set a new record for our PUR product shipments, driven by incredible demand! This milestone reflects the trust our customers place in us and the dedication of our team to deliver excellence.
The momentum is building, and we are just getting started. Become a part of our success, there's so much more to come!
$ORHB 's biologic company, PUR Biologics, has yet another record breaking month!
Sales have soared 58% higher than our previous best.
Join our #distributors and #surgeons experiencing the future of biotech with PUR Biologics.
Learn more at https://t.co/jccUhPMN5u and https://t.co/dehnWd3d4M $ORHB
Streamline your biologic needs with PUR Biologics' comprehensive product line.
No more searching for multiple sources – we provide everything you need in one place. Experience the convenience, reliability, and quality that set us apart. Discover the complete solution with PUR Biologics at https://t.co/jccUhPMN5u
PUR Biologics' sales orders soared with a 42% increase in Feb over Jan! Follow as we transform the future of Spine, marrying sales and scientific expertise to deliver cutting-edge regenerative biological solutions.
$ORHB PUR Biologics is a HippoFi company.
HippoFi's PUR Biologics has delivered over 1,000 biological products for spine surgery patients!
CONGRATS to our Team and to those that will continue to receive the PUR products daily! $ORHB
$ORHB As a result of PUR's ongoing commitment to portfolio enhancement, and the dedication to utilizing a patient's own stem cells, our PURmarrow360 achieved its highest usage in surgeries since launching in the United States of America!
https://t.co/jxBs0CrALe
$ORHB had a great investor Q&A yesterday!
Solid company, revenue expected to exceed $20M for 2024, $3.5B market opportunity, 250 distributors, ZIMMER/BIOMET $ZBH partnership and more.
$ORHB Scott Bauccio (left), the Head of Sales to HippoFi’s PUR Biologics, is here at AAOS sharing with strategic partner, BPB Medica's International Sales Executive, Davide Tarricone, our success selling PURmarrow360 to transform the use of a patient’s own stem cells.
Outstanding growth and performance from our sales and leadership teams!
5 consecutive record breaking months in a row!
Stay tuned for exciting news as our partnership with Zimmer/Biomet $ZBH expands.
$ORHB Unlock the POWER of Native Proteins, Growth Factors, and BMPs see the highlights on YouTube!
PURbonedough Highlights https://t.co/0uileIxrtp via @YouTube
Kicking off 2024 with a Bang!
$ORHB Sales momentum continues into 2024 already hitting record-high shipments. Anticipating huge sales and launch of our ActivOrb tech w ZIMMER/BIOMET $ZBH. ActivOrb promises to be the biggest breakthrough in spinal biologics in the past 22 years!
$ORHB Month over month sales have been strong and continue to grow. Anticipating an outstanding 2024 in sales with December jumping 150%! Stay tuned for another major announcement around our partnership with ZIMMER/BIOMET $ZBH